Telix’s TLX66 in Phase II Academic Study of Pediatric Leukemia

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/21/2026

1. TGT
2. WMT
3. SPY
4. ROST
5. EL
6. ADI
7. LOW
8. MRK
9. BILL
10. NTES

Go back to Telix’s TLX66 in Phase II Academic Study of Pediatric Leukemia
TRANS-LUX CORPORATION (NASDAQ: TLX) Delayed: 12.42 --0 (-0%)
Previous Close $12.42    52 Week High $2.18 
Open $12.42    52 Week Low $0.30 
Day High $12.42    P/E N/A 
Day Low $12.42    EPS $-3.32 
Volume 83